ANI Pharmaceuticals, Inc.
New implant data to be presented at major meeting.
1 source·30/09, 11:12·finviz.com
Director transition without disagreement noted.
1 source·01/12, 12:00·sec.gov
ANI Pharmaceuticals released an updated investor presentation.
1 source·10/11, 13:48·sec.gov
10-Q form submitted!
1 source·07/11, 11:58·sec.gov
Announcement of third quarter financial results.
1 source·07/11, 11:56·sec.gov
Preferred shares converted into common stock successfully.
1 source·26/09, 21:04·sec.gov
ANI Pharmaceuticals announces investor presentations for 2025.
1 source·08/09, 11:00·sec.gov
10-Q form submitted!
1 source·08/08, 11:02·sec.gov
ANI Pharmaceuticals announces Q2 2025 financial results.
1 source·08/08, 10:58·sec.gov
ANI Pharmaceuticals loses court case against CG Oncology.
1 source·29/07, 21:03·sec.gov
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
·finviz.com·27/05, 20:33
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin Gel for the Treatment of Acute Gout Flares
·finviz.com·22/05, 10:59